Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers

Analytical Validation of NavDx+Gyn, a cfDNA-Based Fragmentomic Profiling Assay for HPV-Driven Gynecologic Cancers

<b>Background/Objectives</b>: The NavDx+Gyn blood test detects and quantifies fourteen HPV types in various sample types to provide a reliable means of detecting and monitoring HPV-driven gynecologic cancers. NavDx+Gyn is an extension of the NavDx assay, which identifies five high-risk H...

Full description

Saved in:
Bibliographic Details
Main Authors: Joshua Hutcheson, David Conway, Sunil Kumar, Chloe Wiseman, Syandan Chakraborty, Evgeny Skrypkin, Michael Horan, Alicia Gunning, Cassin Kimmel Williams, Charlotte Kuperwasser, Stephen P. Naber, Piyush B. Gupta
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Diagnostics
Subjects:
NavDx+Gyn
cervical cancer
vaginal cancer
vulvar cancer
HPV
papillomavirus
Online Access:https://www.mdpi.com/2075-4418/15/7/825
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items